Artigo de periodico

Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity (2019)

• Authors:
  • Silva, Raí
  • Poiani, João Gabriel Curtolo
  • Ramos, Ryan S.
  • Costa, Josivan S.
  • Silva, Carlos Henrique Tomich de Paula da
  • Brasil, Davi S. B.
  • Santos, Cleydson B. R.
• USP affiliated authors: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP ; POIANI, JOÃO GABRIEL CURTOLO - FFCLRP
• Unidades: FCFRP; FFCLRP
• DOI: 10.2298/jsc180129047s
• Subjects: DIIDROTESTOSTERONA; RECEPTORES ANDROGÊNICOS; TRIAGEM; NEOPLASIAS; PRÓSTATA
• Keywords: Dihydrotestosterone; Androgen receptor; DFT/6-31+G (d,p); Virtual screening; Derivative of vouacapane; Drug design
• Agências de fomento:
  • Financiado pelo PROPESP
  • Financiado pelo FAPESPA
  • Financiado pela CAPES
• Language: Inglês
• Imprenta:
  • Publisher place: Belgrade
  • Date published: 2019
• Source:
  • Título: Journal of the Serbian Chemical Society
  • ISSN: 0352-5139
  • Volume/Número/Paginação/Ano: v. 84, n. 2, p. 153-174, 2019


Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).

Status:

Artigo publicado em periódico de acesso aberto (Gold Open Access)

Versão do Documento:

Versão publicada (Published version)

Acessar versão aberta:

• PDF de acesso aberto

Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.

---

Download do texto completo

Tipo	Nome	Link
	002969540.pdf	Direct link

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SILVA, Raí et al. Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity. Journal of the Serbian Chemical Society, v. 84, n. 2, p. 153-174, 2019Tradução . . Disponível em: https://doi.org/10.2298/jsc180129047s. Acesso em: 08 abr. 2026.

• APA

  Silva, R., Poiani, J. G. C., Ramos, R. S., Costa, J. S., Silva, C. H. T. de P. da, Brasil, D. S. B., & Santos, C. B. R. (2019). Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity. Journal of the Serbian Chemical Society, 84( 2), 153-174. doi:10.2298/jsc180129047s

• NLM

  Silva R, Poiani JGC, Ramos RS, Costa JS, Silva CHT de P da, Brasil DSB, Santos CBR. Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity [Internet]. Journal of the Serbian Chemical Society. 2019 ; 84( 2): 153-174.[citado 2026 abr. 08 ] Available from: https://doi.org/10.2298/jsc180129047s

• Vancouver

  Silva R, Poiani JGC, Ramos RS, Costa JS, Silva CHT de P da, Brasil DSB, Santos CBR. Ligand- and structure-based virtual screening from 16-((diisobutylamino)methyl)-6α-hydroxyivouacapane-7β,17β-lactone a compound with potential anti-prostate cancer activity [Internet]. Journal of the Serbian Chemical Society. 2019 ; 84( 2): 153-174.[citado 2026 abr. 08 ] Available from: https://doi.org/10.2298/jsc180129047s

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• The impact of natural compounds on the treatment of neurodegenerative diseases
• In silico study of the mechanism of action, pharmacokinetic and toxicological properties of some N-methylanthranilates and their analogs
• Planejamento racional de candidatos a fármacos inibidores de glicogênio sintase cinase - 3 beta (GSK-3ß) em doença de Alzheimer
• Allosteric modulators of potential targets related to Alzheimer's disease: a review
• Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening
• Current topics in computer-aided drug design
• Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
• Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
• General aspects of lead finding and optimization in drug discovery
• Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms